Long-term synaptic plasticity is impaired in rats with lesions of the ventrolateral preoptic nucleus.
Impairment of memory functions has been frequently reported in models of sleep deprivation. Similarly, hippocampal long-term synaptic plasticity has been shown to be sensitive to sleep loss caused by acute sleep restriction. However, such approaches are limited by the stressful nature of sleep deprivation, and because it is difficult to study long-term sleep restriction in animals. Here, we report the effects of chronic sleep loss on hippocampal long-term potentiation (LTP) in a rodent model of chronic partial sleep deprivation. We studied LTP of the Schaffer collateral-CA1 synapses in hippocampal slices prepared from rats with lesions of the ventrolateral preoptic nucleus (VLPO), which suffered reductions in total sleep time for several weeks after lesions. In slices prepared from VLPO-lesioned rats, LTP was impaired proportionally to the amount of sleep loss, and the decline in LTP followed a single exponential function over the amount of accumulated sleep debt. As compared with sham-lesioned controls, hippocampal slices from VLPO-lesioned rats showed a greater response to adenosine antagonists and greater paired-pulse facilitation (PPF). However, exogenous adenosine depressed evoked synaptic transmission and increased PPF in VLPO-lesioned and sham-lesioned rats by equal amounts, suggesting that the greater endogenous adenosine inhibitory tone in the VLPO-lesioned rats is associated with greater ligand accumulation rather than a change in adenosine receptor sensitivity or adenosine-mediated neurotransmitter release probability. LTP in VLPO-lesioned animals was partially restored by adenosine antagonists, suggesting that adenosine accumulation in VLPO-lesioned animals could account for some of the observed synaptic plasticity deficits.
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. earrigon@bidmc.harvard.edu
Elda
E
Arrigoni
Jun
J
Lu
Ramalingam
R
Vetrivelan
Clifford B
CB
Saper
D000818:Animals; D004558:Electric Stimulation / Q000379:methods; D004569:Electroencephalography; D004576:Electromyography; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D005133:Eye Movements / Q000502:physiology; D006624:Hippocampus / Q000166:cytology; D066298:In Vitro Techniques; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology*; D011301:Preoptic Area / Q000293:injuries* / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D043682:Receptor, Adenosine A1 / Q000037:antagonists & inhibitors; D012890:Sleep / Q000502:physiology; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D014851:Wakefulness / Q000502:physiology; D014970:Xanthines / Q000494:pharmacology
D043682:Receptor, Adenosine A1; D014970:Xanthines; C051360:1,3-dipropyl-8-cyclopentylxanthine